Zinc against COVID-19? Symptom surveillance and deficiency risk groups
Review
[키워드] Anti-inflammatory
anti-oxidative
Clinical outcome
clinical trial
condition
conditions
coronavirus 2
COVID-19
Critical
deficiency
disease
Diseases
distribution
Effect
example
group
groups
Health
highlighting
illness duration
immune health
immune response
immune system
individual
Infection
knowledge
overlap
Pandemics
pathogen
progression
Prophylactic
respiratory
resulting
risk
SARS-CoV-2
Severe case
Stress
Support
Surveillance
susceptibility
Symptom
Symptoms
therapy for COVID-19
these symptom
timeline
Trace element
Vaccine development
variety
viral infection
viruses
Zinc
[DOI] 10.1371/journal.pntd.0008895 PMC 바로가기 [Article Type] Review
[DOI] 10.1371/journal.pntd.0008895 PMC 바로가기 [Article Type] Review